Page last updated: 2024-11-10

alpha-ionone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-ionone: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5282108
CHEMBL ID472877
CHEBI ID32319
SCHEMBL ID112670
MeSH IDM0058513

Synonyms (87)

Synonym
.alpha.-ionone
3-buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, (e)-(.+/-.)-
iraldeine
NSC34560 ,
6901-97-9
ionone, alpha
nsc-34560
irisone
beta-lonone
beta-lonone (natural)
einecs 232-396-8
alpha-ionone (natural)
3-buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, (3e)-
fema no. 2594
ionone, alpha-
4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one
(e)-(1)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one
einecs 250-293-6
einecs 204-841-6
cyclocitrylideneacetone, alpha-
.alpha.-cyclocitrylideneacetone
3-buten-2-one, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, (e)-
127-41-3
alpha-ionone
alpha-ionone, >=90%
alpha-ionone, natural, >=86%
alpha-ionone, technical grade, 90%
NCGC00164008-01
(3e)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one
alpha-ionon
trans-alpha-ionone
alpha-cyclocitrylideneacetone
alpha-(e)-ionone
CHEBI:32319 ,
(e)-alpha-ionone
4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one
I0076
alpha-jonone
CHEMBL472877
AKOS000120391
NCGC00164008-02
(e)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one
(+-)-trans-alpha-ionone
i9v075m61r ,
hsdb 8268
unii-i9v075m61r
unii-qp734lin1k
qp734lin1k ,
cas-127-41-3
dtxsid0035160 ,
NCGC00255071-01
tox21_301173
dtxcid8015160
(-)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one
31798-12-6
einecs 250-812-6
einecs 238-362-9
ai3-16056
einecs 230-010-2
nsc 34560
(e)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one
SCHEMBL112670
alpha-ionone [fcc]
(+/-)-trans-.alpha.-ionone
(5e)-ionone
(e)-.alpha.-ionone
(+/-)-.alpha.-ionone
.alpha.-ionone [fhfi]
.alpha.-ionone [mi]
W-108383
mfcd00001565
alpha-ionone, technical, >=90% (gc)
alpha-ionone, analytical standard
alpha-ionone (>90per cent)
(3e)-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-on
(e)-4-(2,6,6-trimethylcyclohex-2-enyl)but-3-en-2-one
DS-3418
Q27114869
a-ionone
STL570068
AKOS016843502
A889200
4-(2,6,6-trimethyl-cyclohex-2-e
CS-0149165
EN300-20383
alpha -ionone
(+/-)-alpha-ionone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
ionone
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
methyl ketoneA ketone of formula RC(=O)CH3 (R =/= H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
pregnane X nuclear receptorHomo sapiens (human)Potency44.66840.005428.02631,258.9301AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency13.87120.000229.305416,493.5996AID743075; AID743079
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1090711Thrips luring activity against female Thrips tabaci (onion thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
AID1090712Thrips luring activity against male New Zealand Thrips obscuratus (flower thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
AID392632Cytotoxicity against androgen-independent human PC3 cells after 72 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.
AID1090713Thrips luring activity against female New Zealand Thrips obscuratus (flower thrips) assessed as ratio of thrips in baited traps to unbaited traps during field trapping study2007Journal of agricultural and food chemistry, Jul-25, Volume: 55, Issue:15
4-pyridyl carbonyl and related compounds as thrips lures: effectiveness for onion thrips and new zealand flower thrips in field experiments.
AID392631Cytotoxicity against androgen-dependent human LNCAP cells with T877A AR mutant after 72 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Feb-15, Volume: 19, Issue:4
Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.72)18.7374
1990's3 (5.17)18.2507
2000's19 (32.76)29.6817
2010's26 (44.83)24.3611
2020's9 (15.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 63.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index63.04 (24.57)
Research Supply Index4.11 (2.92)
Research Growth Index5.36 (4.65)
Search Engine Demand Index102.08 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (63.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other57 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]